JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4801
iShares CMBS ETF
CMBS
$458M
| $217K | ﹤0.01% |
4,520
-514
| -10% | -$24.9K |
2020 Q4
6 quarters
|
|
4802
Vaalco Energy
EGY
$610M
| $217K | ﹤0.01% |
31,255
-123,021
| -80% | -$880K |
2021 Q4
2 quarters
|
|
|
EXAS
4803
PUT
DELISTED
Exact Sciences
EXAS
| $217K | ﹤0.01% |
5,500
| – | – |
2022 Q1
1 quarter
|
|
|
FARM
4804
DELISTED
Farmer Brothers
FARM
| $217K | ﹤0.01% |
46,320
+1,369
| +3% | +$7.73K |
2013 Q2
36 quarters
|
|
4805
Grupo Aeroportuario Centro Norte
OMAB
$4.55B
| $217K | ﹤0.01% |
4,249
| – | – |
2016 Q3
23 quarters
|
|
|
ISLE
4806
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
| $217K | ﹤0.01% |
21,744
-410,100
| -95% | -$4.07M |
2021 Q1
5 quarters
|
|
4807
Princeton Bancorp
BPRN
$294M
| $216K | ﹤0.01% |
7,843
+925
| +13% | +$26.7K |
2018 Q2
16 quarters
|
|
4808
Transcat
TRNS
$844M
| $216K | ﹤0.01% |
3,807
-368
| -9% | -$25.4K |
2019 Q1
13 quarters
|
|
|
GOEV
4809
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $216K | ﹤0.01% |
253
+25
| +11% | +$44K |
2021 Q2
4 quarters
|
|
4810
Farmers & Merchants Bancorp
FMAO
$481M
| $215K | ﹤0.01% |
6,485
-4,635
| -42% | -$173K |
2017 Q4
18 quarters
|
|
4811
ADMA Biologics
ADMA
$2.22B
| $214K | ﹤0.01% |
108,094
+28,988
| +37% | +$57K |
2021 Q4
2 quarters
|
|
|
LONA
4812
PUT
LeonaBio Inc
LONA
$41.3M
| $214K | ﹤0.01% |
+7,000
| New | +$641K |
2022 Q2
0 quarters
|
|
|
ONTF
4813
DELISTED
ON24
ONTF
| $214K | ﹤0.01% |
22,592
+9,296
| +70% | +$113K |
2021 Q1
5 quarters
|
|
4814
Exchange Listed Funds Trust ETC Cabana Target Beta ETF
TDSB
$47.7M
| $213K | ﹤0.01% |
+9,757
| New | +$221K |
2022 Q2
0 quarters
|
|
4815
Viridian Therapeutics
VRDN
$2.15B
| $213K | ﹤0.01% |
18,339
-327
| -2% | -$4.39K |
2021 Q4
2 quarters
|
|
4816
VSE Corp
VSEC
$4.51B
| $213K | ﹤0.01% |
5,675
+682
| +14% | +$26.8K |
2013 Q2
36 quarters
|
|
4817
West Bancorporation
WTBA
$486M
| $213K | ﹤0.01% |
8,739
-796
| -8% | -$19.8K |
2013 Q2
36 quarters
|
|
|
ENFN
4818
DELISTED
Enfusion, Inc.
ENFN
| $213K | ﹤0.01% |
20,880
+5,310
| +34% | +$58.7K |
2021 Q4
2 quarters
|
|
|
FLIC
4819
DELISTED
First of Long Island Corp
FLIC
| $211K | ﹤0.01% |
12,020
-11,027
| -48% | -$204K |
2013 Q2
36 quarters
|
|
|
TE
4820
T1 Energy
TE
$1.1B
| $211K | ﹤0.01% |
30,850
-41,566
| -57% | -$364K |
2021 Q4
2 quarters
|
|
|
SGFY
4821
DELISTED
Signify Health, Inc.
SGFY
| $211K | ﹤0.01% |
15,297
+840
| +6% | +$11.8K |
2021 Q1
5 quarters
|
|
|
SPNE
4822
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $211K | ﹤0.01% |
37,432
+3,518
| +10% | +$30.7K |
2016 Q2
24 quarters
|
|
4823
5E Advanced Materials
FEAM
$135M
| $210K | ﹤0.01% |
+751
| New | +$391K |
2022 Q2
0 quarters
|
|
4824
MediaAlpha
MAX
$513M
| $210K | ﹤0.01% |
21,295
-1,161,657
| -98% | -$14.2M |
2020 Q4
6 quarters
|
|
4825
Workhorse Group
WKHS
$32.1M
| $210K | ﹤0.01% |
27
-11
| -29% | -$104K |
2020 Q2
8 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.